<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: <z:hpo ids='HP_0005305'>Cerebral venous thrombosis</z:hpo> (CVT) is an infrequent process in <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We report the case of a female patient whose initial manifestation of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> was a CVT </plain></SENT>
<SENT sid="2" pm="."><plain>CASE REPORT: A 30-year-old female who presented <z:hpo ids='HP_0002315'>headaches</z:hpo> and diminished visual acuity; on exploring the patient bilateral <z:e sem="disease" ids="C0030353" disease_type="Disease or Syndrome" abbrv="">papilloedema</z:e> was found </plain></SENT>
<SENT sid="3" pm="."><plain>Magnetic resonance imaging revealed the presence of a <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> in the superior and transversal longitudinal sinus </plain></SENT>
<SENT sid="4" pm="."><plain>Complementary explorations showed high levels of <z:hpo ids='HP_0003493'>antinuclear antibodies</z:hpo> with <z:hpo ids='HP_0001882'>leukopenia</z:hpo> and <z:hpo ids='HP_0000093'>proteinuria</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> were negative </plain></SENT>
<SENT sid="6" pm="."><plain>Following treatment with <z:chebi fb="2" ids="50249">anticoagulants</z:chebi>, the patient's condition improved both clinically and radiologically </plain></SENT>
<SENT sid="7" pm="."><plain>Months later a biopsy was performed and revealed a grade IV diffuse <z:hpo ids='HP_0000099'>glomerulonephritis</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: In <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, phenomena such as CVT can be the initial form of presentation of the disease </plain></SENT>
<SENT sid="9" pm="."><plain>The presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> plays a partial role in CVT; other phenomena, such as inflammatory processes, should also be taken into account </plain></SENT>
</text></document>